Distinct neutrophil subpopulations phenotype by flow cytometry in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 50, Issue 3, 2009, Pages 401-409

  Vikentiou, Myrofora ^a,b   Psarra, Katerina ^b   Kapsimali, Violetta ^b   Liapis, Konstantinos ^b   Michael, Michalis ^b   Tsionos, Konstantinos ^c   Lianidou, Evi ^a   Papasteriades, Chryssa ^b  

^a UNIVERSITY OF ATHENS   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

Flow cytometry; Immunophenotype; Lactoferrin; Myelodysplastic syndrome; Myeloperoxidase; Neutrophil granulocytes

Indexed keywords

CD16 ANTIGEN; CD45 ANTIGEN; LACTOFERRIN; MYELOPEROXIDASE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW; CELL SUBPOPULATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; QUALITY CONTROL; REFRACTORY ANEMIA WITH EXCESS BLASTS;

ANTIGENS, CD45; ANTIGENS, SURFACE; BONE MARROW; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; MYELODYSPLASTIC SYNDROMES; NEUTROPHILS; RECEPTORS, IGG; RISK ASSESSMENT;

EID: 67650899433     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190902755497     Document Type: Article

References (32)

1. Ogata, K., Nakamura, K., Yokose, N., Tachibana, M., Taniguchi, O. Iwakiri, R. et al. (2002) Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood, 100, pp. 3887-3896.
2. Aul, C., Bowen, D. T. and Yoshida, Y. (1998) Pathogenesis, etiology and epidemiology of myelodysplastic syndromes. Haematologica, 83, pp. 71-86.
3. Howe, R. B., Porwit-MacDonald, A., Wanat, R., Tehranchi, R. and Hellstrom-Lindberg, E. (2004) The WHO does make a difference. Blood, 103, pp. 3265-3270.
4. Stetler-Stevenson, M., Arthur, D. C., Jabbour, N., Xie, X. Y., Molldrem, J. Barrett, A. J. et al. (2001) Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood, 98, pp. 979-987.
5. Kussick, S. J., Fromm, J. R., Rossini, A., Li, Y., Chang, A. Norwood, T. H. et al. (2005) Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation of myelodysplasia. Am J Clin Pathol, 124, pp. 170-181.
6. Orfao, A., Ortuno, F., De Santiago, M., Lopez, A. and San Miguel, J (2004) Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A, 58, pp. 62-71.
7. Lorand-Metze, I., Ribeiro, E., Lima, C SP, Batista, L. S. and Metze, K. (2007) Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders. Leuk Res, 31, pp. 147-155.
8. Vardiman, J. W. (2003) Myelodysplasic syndromes, chronic myeloproliferative diseases and myelodysplastic/myeloproliferative diseases. Semin Pathol, 20, pp. 154-179.
9. Valent, P., Horny, H. P., Bennett, J. M., Fonatsch, C., Germing, U. Greenberg, P. et al. (2007) Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference. Leuk Res, 31, pp. 727-736.
10. NCCN guidelines for treatment of myelodysplastic syndromes -v.1.2009 (NCCN Clinical Practice Guidelines in Oncology™.
11. Van de Loosdrecht, A., Westers, T., Westra, A., Drager, A., Van der Velden, V. and Ossenkoppele, G. (2008) Identification of distinct prognostic subgroups in low and intermediate-1 risk myelodysplastic syndromes by flow cytometry. Blood, 111, pp. 1067-1077.
12. Kussick, S. J. and Wood, B. L. (2003) Using 4-color flow cytometry to identify abnormal myeloid populations. Am J Clin Pathol, 120, pp. 854-865.
13. Kussick, S. J. and Wood, B. L. (2003) Four-color cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia. Arch Pathol Lab Med, 127, pp. 1140-1147.
14. Elghetany, M. T. (1998) Surface marker abnormalities in myelodysplastic syndromes. Hematologica, 83, pp. 1104-1115.
15. Malcovati, L., Della Porta, M. G., Lunghi, M., Pascutto, C., Vanelli, L. Travaglino, E. et al. (2005) Flow Cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndromes. Leukemia, 19, pp. 776-783.
16. Maynadie, M., Picard, F., Husson, B., Chatelain, B., Cornet, Y. Le Roux, G et al. (2002) Immunophenotypic clustering of myelodysplastic syndromes. Blood, 100, pp. 2349-2356.
17. Ohsaka, A., Saionji, K., Igari, J., Watanabe, N., Iwabuchi, K. and Nagaoka, I. (1997) Altered surface expression of effector cell modules an neutrophil in myelodysplastic syndromes. Br J Haematol, 98, pp. 108-113.
18. Karmon, Y., Manaster, J. and Chezar, J. (2002) Immunophenotyping characterization of myelopoiesis in early and late myelodysplastic syndromes: Use of CD44 as an aid in early diagnosis. Cytometry B Clin Cytometry, 50, pp. 225-230.
19. Wells, D. A., Benesch, M., Loken, M. R., Vallejo, C., Myerson, D. Leisenring, W. M. et al. (2003) Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood, 102, pp. 394-403.
20. Bowen, K. L. and Davis, B. H. (1997) Abnormal patterns of expression of CD16 (Fcr-III) and CD11b (CRIII) in the bone marrow of patients with myelodysplastic syndromes. Lab Hematol, 3, pp. 292-298.
21. Xu, D., Schultz, C., Akker, Y., Cannizzaro, L., Ramesh, K. H. Du, J. et al. (2003) Evidence for expression of early myeloid antigens in mature, non-blast myeloid cells in myelodysplasia. Am J Hematol, 74, pp. 9-16.
22. Benesch, M., Deeg, H. J., Wells, D. and Loken, M. (2004) Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes. Hematology, 9, pp. 171-177.
23. Torsten, H. and Wolfgang, K. (2007) Classification and staging of myelodysplastic syndromes. Hematologic Malignancies: Myelodysplastic Syndromes, pp. 39-53. Springer, Berlin Heidelberg
24. Cherian, S., Moore, J., Bantly, A., Vergilio, J. A., Klein, P. Luger, S. et al. (2005) Peripheral Blood MDS Score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry B Clin Cytom, 64, pp. 9-17.
25. Del Canizo, C M, Fernandez, E., Lopez, A., Vidriales, B., Villaron, E. Arroyo, J. L. et al. (2003) Immunophenotypic analysis of myelodysplastic syndromes. Hematologica, 88, pp. 402-407.
26. Elghetany, M. T., Patel, J., Martinez, J. and Schwab, H. (2003) CD87 as a marker for terminal granulocytic maturation: Assessment of its expression during granulopoiesis. Cytometry B Clin Cytom, 51, pp. 9-13.
27. Elghetany, M. T., Ge, Y., Patel, J., Martinez, J. and Uhrova, H. (2004) Flow cytometric study of neutrophil granulopoiesis in normal bone marrow using an expanded panel of antibodies: Correlation with morphologic assessments. J Clin Lab Anal, 18, pp. 36-41.
28. Pagnucco, G., Giambanco, C. and Gervasi, F. (2006) The role of flow cytometric immunophenotyping in myelodysplastic syndromes. Ann NY Acad Sci, 1089, pp. 383-394.
29. Terstappen, L WMM and Loken, M. R. (1990) Myeloid differentiation in normal bone marrow and acute leukemia assessed by multi-dimensional flow cytometry. Anal Cell Pathol, 2, pp. 229-240.
30. Terstappen, L WMM, Safford, M. and Loken, M. R. (1990) Flow cytometric analysis of human bone marrow. III. Neutrophil maturation. Leukemia, 4, pp. 657-663.
31. Elghetany, M. T. (2002) Surface antigen changes during normal neutrophilic development: A critical review. Blood Cells Mol Dis, 28, pp. 260-274.
32. Elghetany, M. T., Peterson, B., MacCallum, J., Nelson, D. A., Varney, J. F. Sullivan, A. K. et al. (1997) Deficiency of neutrophil granule membrane glycoproteins in the myelodysplastic syndromes: A common deficiency in 216 studied by the cancer and leukemia group B. Leuk Res, 21, pp. 801-806.